Yazeed Sawalha

Yazeed Sawalha's research focuses on the treatment of blood cancers called lymphomas and leukemias, especially studying how well newer immune-based therapies work in real-world patients. Much of the work examines bispecific antibodies and T-cell engager drugs (treatments that redirect a patient's own immune cells to attack cancer cells) as well as CAR-T cell therapy (a treatment that re-engineers a patient's immune cells to fight cancer), often through large multicenter studies pooling patient data across hospitals. This research aims to inform which patients benefit most from these treatments and how to manage side effects and disease relapse.

Publication output has grown substantially over the last decade, rising from about 4 papers per year in 2017 to over 40 in 2025, indicating an accelerating and increasingly active research pace.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026